Related Experiment Videos
[Intraductal breast cancer]
1P. A. Herzen Moscow Research Cancer Institute.
Arkhiv Patologii
|May 2, 2000
Summary
Heterogeneity in intraductal carcinoma, a type of breast cancer, is identified through morphological variants and differentiation. This variability may explain differing treatment outcomes for patients diagnosed with carcinoma in situ.
Area of Science:
- Oncology
- Pathology
- Breast Cancer Research
Context:
- Analysis of 186 cases of intraductal carcinoma.
- Identification of twelve distinct morphological variants.
- Classification into three degrees of differentiation.
Purpose:
- To investigate the heterogeneity of intraductal carcinoma.
- To correlate morphological features with clinical outcomes.
- To explain variability in treatment responses for carcinoma in situ.
Summary:
- Morphological variants and differentiation degrees were identified in 186 intraductal carcinoma cases.
- Significant heterogeneity exists within intraductal carcinoma.
- This heterogeneity is proposed as a reason for varied treatment results in carcinoma in situ.
Impact:
- Highlights the need for precise classification of intraductal carcinoma subtypes.
- Suggests that treatment strategies may need to be tailored based on specific morphological characteristics.
- Improves understanding of "carcinoma in situ" to refine diagnostic and therapeutic approaches.